Saturday - January 18, 2025
CNS Drugs Journal Issues Research Articles in June 2023 Edition
June 19, 2023
CHAM, Switzerland, June 19 -- CNS Drugs, a journal that says it provides researchers and healthcare professionals with information on the aspects of drug therapies used for the management of neurological and psychiatric disorders, published research articles on the following topics in its June 2023 edition:

Leading Article:

* Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage

Current Opinion:

* Pharmacologic . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products